Replies to post #237975 on Biotech Values

[DewDiligence]

There is no more sensitive assay. The idea is to eradicate HBV entirely in a finite treatment period—rather than merely driving the viral load to an undetectable level. The eradication of all disease is determined after the fact by the lack of a relapse during a specified off-treatment period such as six months.